2003
DOI: 10.1046/j.1600-065x.2003.00081.x
|View full text |Cite
|
Sign up to set email alerts
|

Crossing the bridge: large animal models in translational transplantation research

Abstract: Many methods for reducing the immunosuppressive requirements of allotransplantation have been proposed based on a growing understanding of physiological and allospecific immunity. As these regimens are developed for clinical application, they require validation in models that are reasonably predictive of their performance in humans. This article provides an overview of the large animal models commonly used to test immunomodulatory organ transplant protocols. The rationale for the use of large animals and the e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
103
0

Year Published

2005
2005
2016
2016

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 136 publications
(103 citation statements)
references
References 206 publications
(222 reference statements)
0
103
0
Order By: Relevance
“…Dev. 55: [225][226][227][228][229][230] 2009) t present, pigs are not only considered important livestock but are also essential large-animal models in various types of biomedical research [1][2][3][4][5][6]. Furthermore, due to recent technological advances in genetic modification and somatic cell cloning, the range of applications for porcine models has increased markedly [7][8][9][10][11][12][13][14].…”
mentioning
confidence: 99%
“…Dev. 55: [225][226][227][228][229][230] 2009) t present, pigs are not only considered important livestock but are also essential large-animal models in various types of biomedical research [1][2][3][4][5][6]. Furthermore, due to recent technological advances in genetic modification and somatic cell cloning, the range of applications for porcine models has increased markedly [7][8][9][10][11][12][13][14].…”
mentioning
confidence: 99%
“…Antibodies used in primates such as the anti-CD3 immunotoxin are not usable in humans because of the different protein structure, so that antibodies against the same epitope do not cross-react between species. In humans, alemtuzumab (anti-CD52) and anti-thymocyte globulin (ATG) have been the clinically used depletional antibody therapy (Kirk, 2003).…”
Section: Cell Depletionmentioning
confidence: 99%
“…In addition, porcine and human kidneys demonstrate similarities in the pathophysiology of ischemia reperfusion injury (IRI), biochemistry, and immunological parameters 14 . Thus, porcine renal transplantation is well-suited to investigate new organ preservation methods for marginal kidney grafts [15][16][17] , model human IRI 18 , study immunological pathways and allograft tolerance 19 , provide surgical training [20][21][22] , test new pharmacological therapies 23 , implement new medical devices, and study new immunological mechanisms in xenotransplantation [24][25][26] .…”
Section: Introductionmentioning
confidence: 99%